321 related articles for article (PubMed ID: 15460561)
21. Biotechnology: delivering on the promise.
Greenwood JC
Sci Transl Med; 2010 Jan; 2(13):13cm1. PubMed ID: 20371460
[TBL] [Abstract][Full Text] [Related]
22. The promise in selling stem cells.
Pollack A
N Y Times Web; 2001 Aug; ():BU1, BU11. PubMed ID: 12155690
[No Abstract] [Full Text] [Related]
23. Science and law. Intellectual property and human embryonic stem cell research.
Loring JF; Campbell C
Science; 2006 Mar; 311(5768):1716-7. PubMed ID: 16556826
[No Abstract] [Full Text] [Related]
24. Biotech under Barack.
Fox JL
Nat Biotechnol; 2009 Mar; 27(3):237-44. PubMed ID: 19270669
[No Abstract] [Full Text] [Related]
25. Causative vs. beneficial complicity in the embryonic stem cell debate.
Robertson JA
Conn Law Rev; 2004; 36(4):1099-113. PubMed ID: 15868676
[No Abstract] [Full Text] [Related]
26. India shuts door on embryonic export market.
Jayaraman KS
Nature; 2002 Sep; 419(6904):238. PubMed ID: 12239528
[No Abstract] [Full Text] [Related]
27. Federally funded stem cell research: a good deal for the taxpayer and consumer.
Resnikoff DA
Loyola Consum Law Rev; 2001; 14(1):36-56. PubMed ID: 15977330
[No Abstract] [Full Text] [Related]
28. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
29. Indian Biotech Bazaar: a swot analysis.
Kumar A
Biotechnol J; 2007 May; 2(5):543-5. PubMed ID: 17479978
[TBL] [Abstract][Full Text] [Related]
30. The business of human embryonic stem cell research and an international analysis of relevant laws.
De Trizio E; Brennan CS
J Biolaw Bus; 2004; 7(4):14-22. PubMed ID: 15675095
[TBL] [Abstract][Full Text] [Related]
31. Stem cell research in Canada: business opportunities for U.S. companies.
Reicin C; McMahon E
J Biolaw Bus; 2005; 8(1):61-4. PubMed ID: 16538805
[TBL] [Abstract][Full Text] [Related]
32. Stem cells: public policy and ethics.
Towns CR; Jones DG
N Z Bioeth J; 2004 Feb; 5(1):22-8. PubMed ID: 15597489
[TBL] [Abstract][Full Text] [Related]
33. Stem cells. Restiveness grows at NIH over Bush research restrictions.
Holden C
Science; 2005 Apr; 308(5720):334-5. PubMed ID: 15831721
[No Abstract] [Full Text] [Related]
34. Gaining medical momentum.
Blake D
Nature; 2004 Jun; 429(6991 Suppl):19-23. PubMed ID: 15175707
[No Abstract] [Full Text] [Related]
35. Regulating small things: genes, gametes and nanotechnology.
Bennett B
J Law Med; 2007 Aug; 15(1):153-60. PubMed ID: 17902497
[TBL] [Abstract][Full Text] [Related]
36. Stem cells. U.S. public supports stem cell research.
Holden C
Science; 2005 Oct; 310(5747):416. PubMed ID: 16239443
[No Abstract] [Full Text] [Related]
37. Misapplied ethical considerations: U.S. federal stem cell mandates lack global focus and market foresight.
Fowler HL
Cornell Int Law J; 2004; 36(3):521-44. PubMed ID: 16602208
[No Abstract] [Full Text] [Related]
38. Embryo research: is disclosing commercial intent enough?
de Lacey S
Hum Reprod; 2006 Jul; 21(7):1662-7. PubMed ID: 16571639
[TBL] [Abstract][Full Text] [Related]
39. Biotechnology in India.
Ghosh PK
Australas Biotechnol; 1993; 3(4):214-5, 218-22. PubMed ID: 7764132
[TBL] [Abstract][Full Text] [Related]
40. Governing stem cell research in California and the USA: towards a social infrastructure.
Winickoff DE
Trends Biotechnol; 2006 Sep; 24(9):390-4. PubMed ID: 16843559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
